The staining’s extent and intensity are also essential; tumors with diffuse, strong expression of multiple smooth muscle markers should be, in a proper morphological context, classified as smooth muscle tumors, even if there is a focal expression of CD10 or IFITM1. The gene discussed is IFITM1; the disease is smooth muscle tumor.